Navigation Links
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update
Date:2/1/2010

Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system.

Morrisville, NC (PRWEB) February 1, 2010 -- Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies, within a closed pill vial, the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.

According to a 2006 report from the Institute of Medicine, at least 1.5 million Americans are injured by medication errors every year, many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.

The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications, which equates to more than 20,000 NDCs. In addition, PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined, these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.

After multiple customer focus groups were conducted, the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.

Centice Corporation provides its customers with storage and reporting capabilities to enhance quality control in the pharmacy. Anything scanned and/or analyzed through the PASS Rx system is captured for future reporting on how many scripts were filled, how many were run through PASS Rx and how many errors have been caught.

Periodic updates are provided remotely so that Centice may provide its customers with the most up-to-date information as drugs are added or removed from the library and for faster customer service.

”We are thrilled to offer our pharmacy customers an improved solution that will assist them in increasing their quality and efficiency, ultimately allowing them to do what they do best, spend more time consulting with their patients,” said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.

About Centice Corporation
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at www.centice.com.

# # #

Read the full story at http://www.prweb.com/releases/2010/02/prweb3537194.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th
2. Centage Corporation Reports 16% Growth in 2009; Planning Maestro, Business Performance Management Software Implementations on the Rise
3. Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
4. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
5. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
6. Providence Service Corporation Comments on Senate Health Care Reform
7. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
8. Service Corporation International Extends Offer for Keystone North America Inc.
9. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
10. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update  
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: